Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Edwards lifesciences corporation symbols : GLAXF save search
Global Hepatorenal Syndrome Treatment Market Research Report (2021 to 2026) - by Type, Treatment, End-user and Region
Published: 2022-01-04 (Crawled : 21:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.57%
H: 1.57%
C: 0.28%
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 3.68%
H: 0.0%
C: 0.0%
MDT | $79.19 0.14% 0.0% 6.1M
|
Health Technology
|
| O: 1.01%
H: 0.0%
C: 0.0%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.52%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.96%
H: 0.0%
C: 0.0%
EW | News | $86.45 -0.91% 0.0% 3.1M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
BDX | $233.15 0.41% 0.15% 890K
|
Health Technology
|
| O: -0.76%
H: 0.0%
C: 0.0%
BAX | $39.65 0.33% 0.0% 2.3M
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.91%
H: 0.0%
C: 0.0%
LJPC | $6.22 0.0%
|
Health Technology
|
| O: 0.21%
H: 4.19%
C: -6.06%
CPIX | $1.57 6.02% 1.4K
|
Health Technology
|
| O: -13.36%
H: 0.0%
C: 0.0%
BIVI | News | $0.488 3.52% 3.4% 1.4M
|
Health Technology
|
| O: 2.86%
H: 12.1%
C: 12.1%
treatment renal research syndros
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.